or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVS F 0.74 0.48

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Antibiotics Biotechnology Blood Test Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Drugs Eye Eye Care Eye Care Products Eyewear Healthcare Products Infectious Diseases Intraocular Lens Lens Care Products Lenses
    Industries: Drug Manufacturers - Major

    Recent News for PowerShares DWA Developed Market Technical Leaders Portfolio & its Holdings

    Date Stock Title
    Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
    Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
    Nov 21 NVS Novartis raises mid-term sales guidance
    Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
    Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
    Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
    Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
    Nov 15 NVS FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
    Nov 15 NVS Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
    Nov 15 NVS Ouch: Why a Healthcare Selloff Really Hurts in Europe
    The PowerShares DWA Developed Markets Momentum Portfolio (Fund) is based on the Dorsey Wright® Developed Markets Technical Leaders Index ND (Index). The Fund will normally invest at least 80% of its total assets in securities of developed economies within Dorsey, Wright & Associates, LLC's classification definition, excluding US companies listed on a US stock exchange. This Index includes approximately 100 companies that possess powerful relative strength characteristics and are domiciled in developed markets including, but not limited to Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the United Kingdom. The Index excludes US companies listed on a US stock exchange. The Index is computed using the net return, which withholds applicable taxes for non-resident investors. The Fund and the Index are rebalanced and reconstituted quarterly. Effective on or about Oct. 4, 2013, the name of the Fund changed from PowerShares DWA Developed Markets Technical Leaders Portfolio to PowerShares DWA Developed Markets Momentum Portfolio
    Exchange Traded Fund ETF Exchange Traded Funds Invesco Powershares Relative Strength Nasdaq 100 Settlement Index Leaders Index
    Back to the Main PIZ Page...